光広 木田

Professor

Kitasato University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Year:

2026

Year:

2026

Background and Aim Stereomicroscopic on‐site evaluation (SOSE) is a rapid evaluation method for endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) with a high diagnostic sensitivity when the stereomicroscopically visible white core (SVWC) cut‐off value (≥ 11 mm) is met. We prospectively examined the association between SVWCs and the adequacy of tissue specimens, assuming subsequent comprehensive genome profiling (CGP). Methods This study included 66 consecutive patients with suspected unresectable pancreatic cancer who underwent EUS‐TA. The primary endpoint was the frequency of combined samples with ≥ 20% tumor cell content that met over twice the SVWC (T‐SVWC) cut‐off value, achieved through multiple punctures. The secondary endpoints were the number of punctures, the percentage of SVWC cut‐off values, adverse events, the positive diagnosis rate, and the tissue section area. Results The median number of EUS‐TA punctures for suspected unresectable pancreatic cancer was 3 (range, 3–4); SVWC and T‐SVWC cut‐off values were obtained in 171/206 specimens and 65/66 patients, respectively. There were no EUS‐TA‐related adverse events. The positive diagnosis rate of EUS‐TA was 95.5%. Among the 63 patients meeting the T‐SVWC cut‐off value in pathological diagnoses, the median tumor cell content was 40% (range, 5–80%), with 57 patients having tumor cell content ≥ 20%. The median tissue section area was 15 (range, 3–40) mm 2 . Conclusions When performing EUS‐TA for unresectable pancreatic cancer with the intention of subsequent CGP, obtaining a high tumor cell content (≥ 20%) by assessing the T‐SVWC cut‐off value via SOSE may serve as a novel indicator for on‐site estimation of CGP suitability for EUS‐TA specimens.

Year:

2024

Background/Aims: To validate endoscopic ultrasound-guided tissue acquisition (EUS-TA) used in conjunction with stereomicroscopic on-site evaluation (SOSE) as a preoperative diagnostic tool for resectable pancreatic cancer (R-PC) and borderline resectable PC (BR-PC).Methods: Seventy-eight consecutive patients who underwent EUS-TA for suspected R-PC or BR-PC were enrolled. The primary endpoint was the sensitivity of EUS-TA together with SOSE based on the stereomicroscopically visible white core (SVWC) cutoff value. One or two sites were punctured by using a 22-gauge biopsy needle for EUS-TA, based on the SOSE findings.Results: We collected 99 specimens from 56 and 22 patients with R-PC and BR-PC, respectively. Based on the SOSE results, we performed 57 procedures with one puncture. The SVWC cutoff values were met in 73.7% and 73.1% of all specimens and in those obtained during the first puncture, respectively. The final diagnoses were malignant and benign tumors in 76 and two patients, respectively. The overall sensitivity, specificity, and accuracy of EUS-TA for the 78 lesions were 90.8%, 100%, and 91.0%, respectively. The sensitivity for malignant diagnosis based on the SVWC cutoff value were 89.5% and 90.4% for the first puncture and all specimens, respectively.Conclusions: The sensitivity of EUS-TA in conjunction with SOSE for malignancy diagnosis in patients with suspected R-PC or BR-PC was 90.4%.

Year:

2024

Collaborators (2)

Masayoshi Tadehara

Kitasato University

JAPAN
View details

Kosuke Okuwaki

Kitasato University

JAPAN
View details